Piperazine citrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for piperazine citrate and what is the scope of freedom to operate?
Piperazine citrate
is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Sanofi Aventis Us, Bluline, Alpharma Us Pharms, Lannett, Luitpold, Solvay, and Impax Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.Summary for piperazine citrate
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 8 |
| NDAs: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Patent Applications: | 48 |
| DailyMed Link: | piperazine citrate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for piperazine citrate
US Patents and Regulatory Information for piperazine citrate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | BRYREL | piperazine citrate | SYRUP;ORAL | 017796-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bluline | MULTIFUGE | piperazine citrate | SYRUP;ORAL | 009452-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Luitpold | PIPERAZINE CITRATE | piperazine citrate | SYRUP;ORAL | 080671-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alpharma Us Pharms | PIPERAZINE CITRATE | piperazine citrate | SYRUP;ORAL | 080774-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Solvay | VERMIDOL | piperazine citrate | SYRUP;ORAL | 080992-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
